27 November 2008

Executive Director's Presentation at the AGM

07 November 2008

UBS Healthcare Investor Conference

21 November 2007

Presentation to the AGM by Chief Scientific Adviser

23 November 2006

Presentation to the AGM/EGM by Chief Scientific Adviser

15 November 2006

AGM Presentation-Today’s Commercial & Clinical Reality

19 October 2005

'Today's Clinical Reality' - Presentation to the 5th Annual Stem Cells & Regenerative Medicine Conference in Pittsburgh, United States.

13 October 2005

MESOBLAST – INVESTOR UPDATE PRESENTATION: Australian adult stem cell company, Mesoblast Limited (ASX: MSB), today provided a presentation update.

Key points in the presentation to the investment community by Mesoblast’s Executive Chairman, Mr Michael Spooner, include:

• a very compelling business model
• a broad based stem cell technology platform
• a unique competitive market position
• massive unmet markets for the company’s technology
• a structured IP strategy to protect our markets
• on track to deliver FDA regulatory approvals
• focused on milestones, outcomes, global success
• exciting and highly visible progress, clearly communicated on an ongoing basis.

27 July 2005

Presentation by Mesoblast Founder and Chief Scientific Adviser, Professor Silviu Itescu, to members of the investment community and to the Australian Biotechnology Summit in Sydney on 26 July, where he was a keynote speaker.

31 March 2005

INVESTOR PRESENTATION : Presentation by Mesoblast Founder and Chief Scientific Adviser, Professor Silviu Itescu, to institutional fund managers at Lodge Partners' small and mid-cap conference in Victoria on 31 March 2005.

14 January 2005

Mesoblast Presentation 1

Investor Centre

• ASX Watch
• Presentations
• Annual Reports
• Expert Analysis
• Scientific Publications
• Prospectus
• FAQ